Cargando…

Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines

Dermatophytes are associated with superficial infections in humans worldwide. The aim of the present study was to determine the species distribution and susceptibility patterns of clinical dermatophytes. Samples received for routine mycological processing from 124 suspected cases attending a dermato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dabas, Yubhisha, Xess, Immaculata, Singh, Gagandeep, Pandey, Mragnayani, Meena, Suneeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715923/ https://www.ncbi.nlm.nih.gov/pubmed/29371535 http://dx.doi.org/10.3390/jof3020017

Ejemplares similares

Geotrichum candidum in Infective Endocarditis
por: Meena, Suneeta, et al.
Publicado: (2017)

Epidemiology and Antifungal Susceptibility Patterns of Invasive Fungal Infections (IFIs) in India: A Prospective Observational Study
por: Dabas, Yubhisha, et al.
Publicado: (2021)

Change of Antibiotic Susceptibility Testing Guidelines from CLSI to EUCAST: Influence on Cumulative Hospital Antibiograms
por: Wolfensberger, Aline, et al.
Publicado: (2013)

Susceptibility of Dermatophytes to Thiabendazole Using CLSI Broth Macrodilution
por: Robledo-Leal, Efrén, et al.
Publicado: (2012)

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
por: Cusack, T.P., et al.
Publicado: (2019)

Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints
por: Sachu, Arun
Publicado: (2023)

Serum galactomannan antigen as a prognostic and diagnostic marker for invasive aspergillosis in heterogeneous medicine ICU patient population
por: Dabas, Yubhisha, et al.
Publicado: (2018)

Prognostic Scores and Azole-Resistant Aspergillus fumigatus in Invasive Aspergillosis from an Indian Respiratory Medicine ICU (ICU Patients with IA Suspicion)
por: Dabas, Yubhisha, et al.
Publicado: (2021)

Invasive Fungal Infections 2021
por: Xess, Immaculata, et al.
Publicado: (2022)

Time to switch from CLSI to EUCAST? A Southeast Asian perspective
por: Cusack, T.P., et al.
Publicado: (2019)

Prevalence of susceptibility patterns of opportunistic bacteria in line with CLSI or EUCAST among Haemophilus parainfluenzae isolated from respiratory microbiota
por: Kosikowska, Urszula, et al.
Publicado: (2020)

COVID-19 Associated Mucormycosis: Ramping up our services during crisis
por: Xess, Immaculata, et al.
Publicado: (2022)

1269. Differences in Interpretative Breakpoints Between CLSI, FDA and EUCAST Impact Reporting of Susceptibility and Resistance to Cefiderocol
por: Yamano, Yoshinori, et al.
Publicado: (2020)

In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values
por: Jang, Min Joong, et al.
Publicado: (2013)

Haemophilus influenzae blood-stream infection and third-generation cephalosporin susceptibility testing: a comparative case study using EUCAST and CLSI guidelines
por: Merlino, John, et al.
Publicado: (2023)

Chromoblastomycosis in India: Review of 169 cases
por: Agarwal, Reshu, et al.
Publicado: (2017)

P078 Baseline antifungal usage patterns and knowledge regarding management of invasive fungal infections as a part of a multidisciplinary antifungal stewardship (AFS) program
por: Sachdev, Janya, et al.
Publicado: (2022)

Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement
por: Gaur, Priyanka, et al.
Publicado: (2023)

The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing
por: Vahedi-Shahandashti, Roya, et al.
Publicado: (2023)

P200 Lodderomyces elongisporus fungemia in a late post-operative patient with ventricular septal defect: case report
por: Gourav, Sudesh, et al.
Publicado: (2022)

P405 Diagnostic performance of MucorGenius® real-time polymerase chain reaction assay on tissue samples for the diagnosis of mucormycosis
por: Pandey, Mragnayani, et al.
Publicado: (2022)

Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies
por: Lemes, Raquel M.L., et al.
Publicado: (2010)

In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST
por: Fatahinia, Mahnaz, et al.
Publicado: (2020)

Clinical Implications of Antifungal Drug Susceptibility Testing of Dermatophytes
por: Khurana, Ananta, et al.
Publicado: (2019)

Antifungal Combinations in Dermatophytes
por: Brescini, Lucia, et al.
Publicado: (2021)

Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
por: Meletiadis, Joseph, et al.
Publicado: (2022)

Regional Differences in Antifungal Susceptibility of the Prevalent Dermatophyte Trichophyton rubrum
por: Jiang, Y., et al.
Publicado: (2020)

Molecular Identification and Antifungal Susceptibility Patterns of Dermatophytes Isolated from Companion Animals with Clinical Symptoms of Dermatophytosis
por: Katiraee, Farzad, et al.
Publicado: (2021)

P396 Utility of nasal swabs as samples for the diagnosis of Mucormycosis using molecular methods for detection
por: Chowdhury, Souradeep, et al.
Publicado: (2022)

Antifungal susceptibility and virulence factors of clinically isolated dermatophytes in Tehran, Iran
por: Afshari, Mohammad Ali, et al.
Publicado: (2016)

Antifungal Drug Susceptibility Testing of Dermatophytes: Laboratory Findings to Clinical Implications
por: Dogra, Sunil, et al.
Publicado: (2019)

Comparison of Clinical Laboratory Standards Institute (CLSI) Microdilution Method and VITEK 2 Automated Antifungal Susceptibility System for the Determination of Antifungal Susceptibility of Candida Species
por: Dalyan Cilo, Burcu, et al.
Publicado: (2021)

Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility
por: Kahlmeter, Gunnar, et al.
Publicado: (2020)

CLSI announces availability of new CLSI microbiology documents
Publicado: (2007)

1597. Evaluation of Ceftaroline Resistance (CPT-R) in Chile Across Time and a Comparison of CLSI vs. EUCAST Breakpoints in Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Khan, Ayesha, et al.
Publicado: (2019)

In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies
por: Rivero-Menendez, Olga, et al.
Publicado: (2021)

Antifungal Susceptibility of Dermatophytes Isolated From Cutaneous Fungal Infections: The Vietnamese Experience
por: Van, Tro Chau, et al.
Publicado: (2019)

Antifungal Susceptibility and Mutations in the Squalene Epoxidase Gene in Dermatophytes of the Trichophyton mentagrophytes Species Complex
por: Kong, Xue, et al.
Publicado: (2021)

A Study of In vitro Antifungal Susceptibility Patterns of Dermatophytic Fungi at a Tertiary Care Center in Western India
por: Poojary, Shital, et al.
Publicado: (2019)

PREVALENCE, IDENTIFICATION AND ANTIFUNGAL SUSCEPTIBILITY OF DERMATOPHYTES CAUSING TINEA CAPITIS IN A LOCALITY OF NORTH CENTRAL NIGERIA
por: Ayodele, Ekundayo Halimat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gjgcuvu0ls1aa601fsjplri78m